News & Updates

In patients with chronic heart failure (HF), the addition of the oral relaxin family peptide receptor 1 (RXFP1) agonist AZD5462 to guideline-directed medical therapies (GDMTs) may help improve cardiac remodelling and haemodynamics across a wide range of left ventricular ejection fraction (LVEF), according to the phase IIb LUMINARA study.

Higher circulating apolipoprotein A (ApoE) concentrations appear to increase the risk for incidence major adverse cardiovascular events (MACE), ischaemic heart disease (IHD), and heart failure, suggests a study.

Cumulative blood pressure (BP) exposure over the previous 10 years results in improved prediction of incident cardiovascular events and mortality beyond that derived from a single value, according to a study.

Short-term exposure to ambient fine particulate matter (PM2.5) appears to increase the risk of cardiovascular mortality, suggests a study.

Assessment of high-sensitivity cardiac troponin I (hs-cTnI) trajectories during the immediate peripartum period hint at delivery as a physiologic cardiovascular “stress test,” according to a study.

Immediate ambulatory electrocardiographic (ECG) monitoring initiated among patients with syncope in the emergency department (ED) falls short of preventing recurrent syncope over 1 year, according to the ASPIRED study presented at ESC Congress 2026.